For a patient of NSCLC having N2 (stage III) disease, which of the following is an accepted management option :

Q. For a patient of NSCLC having N2 (stage III) disease, which of the following is an accepted management option :

A.            Concurrent chemoradiation followed by adjuvant chemotherapy

B.            Concurrent chemoradiation followed by immune checkpoint inhibitor therapy

C.            Both of the above

D.            Neither I nor 2

Answer: Both of the above